REG - Bank of Montreal - Final Terms - Bank of Montreal

Bank of MontrealAnnouncement

26/11/2025 16:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251126:nRSZ1504Ja&default-theme=true

RNS Number : 1504J  Bank of Montreal  26 November 2025

 

 

 

Regulatory Announcement

 

Publication of Pricing Supplement

 

Bank of Montreal has agreed to issue USD 30,000,000 Multi-Callable Fixed Rate
Senior Notes due November 25, 2040, Series 444 (the "Notes") pursuant to its
U.S.$40,000,000,000 Note issuance Programme (the "Programme").

 

The following document constitutes the pricing supplement dated November 21,
2025 (the "Pricing Supplement") relating to the admission to trading of the
Notes on the International Securities Market  pursuant to section 3.5 of the
London Stock Exchange's  ISM Rulebook and must be read in conjunction with
the prospectus dated June 27, 2025 and the supplementary admission particulars
dated August 26, 2025 (together, the "Prospectus").  Full information on Bank
of Montreal and the offer of the Notes is only available on the basis of the
combination of the Pricing Supplement and the Prospectus.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus and the Pricing
Supplement may be addressed to and/or targeted at persons who are residents of
particular countries (specified in the Prospectus) only and is not intended
for use and should not be relied upon by any person outside these countries
and/or to whom the offer contained in the Pricing Supplement is not addressed.
Prior to relying on the information contained in the Pricing Supplement you
must ascertain from the Prospectus, as supplemented by these Pricing
Supplement, whether or not you are part of the intended addressees of the
information contained therein.

 

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") and are subject to
U.S. tax law requirements.  Subject to certain exceptions, the Notes may not
be offered, sold or delivered in the United States or to or for the account of
U.S. persons (as defined in Regulation S under the Securities Act).  No
public offering of the Notes is being made in the United States.

 

Your right to access this service is conditional upon complying with the above
requirement.

 

UK MiFIR professionals / ECPs-only / No PRIIPs KID - Manufacturer target
market (UK MiFIR product governance) is eligible counterparties and
professional clients only (all distribution channels).  No PRIIPs key
information document (KID) has been prepared as not available to retail in EEA
and the UK.

 

To view the full document, please paste the following URL into the address bar
of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/1504J_1-2025-11-26.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1504J_1-2025-11-26.pdf)

 

For further information, please contact:

 

Zoë Kruis

Corporate Secretary's Dept.

Phone: (416) 643-2628

Email: zoe.kruis@bmo.com (mailto:zoe.kruis@bmo.com)

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PFTBUBDBRGDDGUL



            Copyright 2019 Regulatory News Service, all rights reserved